EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review

Halliru Zailani, Senthil Kumaran Satyanarayanan, Wei-Chih Liao, Kuan-Pin Su, Jane Pei-Chen Chang

Current Nutrition Reports · 2025

DOI: 10.1007/s13668-024-00599-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Nutrition Reports, 2025. Verfasst von Halliru Zailani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: COVID-19, Fatty Acids, Omega-3, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 136 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, An-Nan Hospital, China Medical University, Tainan, Taiwan, Higher Education Sprout Project by the Ministry of Education, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF THE REVIEW: Mounting evidence indicates that individuals with chronic obstructive pulmonary disease (COPD) face a heightened risk of severe outcomes upon contracting coronavirus disease 2019 (COVID-19). Current medications for COVID-19 often carry side effects, necessitating alternative therapies with improved tolerance. This review explores the biological mechanisms rendering COPD patients more susceptible to severe COVID-19 and investigates the potential of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in mitigating the severity of COVID-19 in COPD patients. RECENT FINDINGS: Current evidence indicates that COPD patients are at an increased risk of severe COVID-19 due to factors including compromised pulmonary function, dysregulated inflammation, weakened immune response, increased oxidative stress, elevated expression of angiotensin-converting enzyme (ACE2) receptors in the lungs, and genetic predispositions. Remarkably, n-3 PUFAs exhibit the potential in ameliorating the clinical outcomes of COPD patients with COVID-19 by modulating inflammation, reinforcing the body's antioxidant defenses, reducing viral entry and replication, and enhancing immunity. N-3 PUFAs hold potential for improving COVID-19 outcomes in patients with COPD. However, there has been limited investigation into the therapeutic effects of n-3 PUFAs in enhancing clinical outcomes for COPD patients. Rigorous clinical studies are essential to evaluate the impact of n-3 PUFAs on COPD patients with concurrent COVID-19 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Fatty Acids, Omega-3Pulmonary Disease, Chronic ObstructiveHumansInflammationLungOxidative StressSARS-CoV-2

Stichwörter der Autor:innen

AntioxidantsCOPDCOVID-19CytokinesOmega-3 polyunsaturated fatty acidsSpecialised pro-resolving mediators

Substanzen

Fatty Acids, Omega-3

Autor:innen und Institutionen

  • Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung, Taiwan.
  • Graduate Institute of Nutrition, China Medical University, Taichung, Taiwan.
  • Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.
  • Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong Science Park, Hong Kong, China.
  • Division of Pulmonary and Critical Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. weichih.liao@gmail.com.
  • College of Medicine, China Medical University, Taichung, Taiwan. weichih.liao@gmail.com.

Förderung

  • Ministry of Science and Technology, Taiwan
  • An-Nan Hospital, China Medical University, Tainan, Taiwan
  • Higher Education Sprout Project by the Ministry of Education, Taiwan
  • China Medical University, Taiwan
  • China Medical University Hospital

Zitieren

APA

Zailani, H., Satyanarayanan, S. K., Liao, W. C., Su, K. P., & Chang, J. P. (2025). Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review. Current Nutrition Reports. https://doi.org/10.1007/s13668-024-00599-9

Vancouver

Zailani H, Satyanarayanan SK, Liao WC, Su KP, Chang JP. Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review. Current Nutrition Reports. 2025. doi:10.1007/s13668-024-00599-9

BibTeX
@article{Zailani2025,
  author = {Zailani, Halliru and Satyanarayanan, Senthil Kumaran and Liao, Wei-Chih and Su, Kuan-Pin and Chang, Jane Pei-Chen},
  title = {Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review},
  journal = {Current Nutrition Reports},
  year = {2025},
  doi = {10.1007/s13668-024-00599-9}
}
Kostenlos starten →